PAREXEL, Sanofi Advance the Use of Wearable Devices in Life Science Industry

PAREXEL International Corporation, a leading global biopharmaceutical services organization, has just announced a collaboration with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials.

Wearables have the potential to address several challenges related to clinical trials and improve execution by increasing patients’ ability to participate, driving patient engagement, and creating more opportunities for decentralized trial sites.

The PAREXEL-Sanofi collaboration is designed to further explore the potential of patient sensors and wearable devices to remotely collect patient data during clinical trials.

“We believe the use of wearables to collect data from trial participants represents a breakthrough in the digital transformation within the industry,” said Xavier Flinois, President of PAREXEL Informatics. “Working with Sanofi, we believe we have a strong opportunity to streamline and automate data collection from multiple devices, collect high-quality data remotely and generate meaningful results, all while reducing burden on patients and sites, as well as lowering costs.”

This post was written by:

- who has written 2131 posts on mHealthWatch.


Contact the author

0 comments
Advert